Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Edgewise Therapeutics (EWTX)
NASDAQ:EWTX
Edgewise Therapeutics (EWTX) Stock Price & Analysis
172 Followers
EWTX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$5.12 - $23.50
Previous Close$22.2
Volume826.17K
Average Volume (3M)768.81K
Market Cap
$2.07B
Enterprise Value$1.55B
Total Cash (Recent Filing)$532.76M
Total Debt (Recent Filing)$5.25M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Aug 07, 2024EPS Estimate
-$0.35Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.53
Shares Outstanding93,398,767
10 Day Avg. Volume589,426
30 Day Avg. Volume768,809
Standard Deviation0.22
R-Squared0.00094
Alpha0.00201
Financial Highlights & Ratios
Price to Book (P/B)4.99
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-14.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-22.88
Forecast
1Y Price Target
$34.60Price Target Upside61.01% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
Edgewise Therapeutics News
PremiumStock Analysis & Ideas
TipRanks ‘Perfect 10’ List: 3 Stocks that Analysts Rate a Strong Buy
Ownership Overview
43.53% Insiders
13.70% Mutual Funds
9.45% Other Institutional Investors
33.32% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
EWTX FAQ
What was Edgewise Therapeutics’s price range in the past 12 months?
Edgewise Therapeutics lowest stock price was $5.12 and its highest was $23.50 in the past 12 months.
What is Edgewise Therapeutics’s market cap?
Currently, no data Available
When is Edgewise Therapeutics’s upcoming earnings report date?
Edgewise Therapeutics’s upcoming earnings report date is Aug 07, 2024 which is in 20 days.
How were Edgewise Therapeutics’s earnings last quarter?
Edgewise Therapeutics released its earnings results on May 09, 2024. The company reported -$0.33 earnings per share for the quarter, beating the consensus estimate of -$0.391 by $0.061.
Is Edgewise Therapeutics overvalued?
According to Wall Street analysts Edgewise Therapeutics’s price is currently Undervalued.
Does Edgewise Therapeutics pay dividends?
Edgewise Therapeutics does not currently pay dividends.
What is Edgewise Therapeutics’s EPS estimate?
Edgewise Therapeutics’s EPS estimate is -$0.35.
How many shares outstanding does Edgewise Therapeutics have?
Edgewise Therapeutics has 93,398,766 shares outstanding.
What happened to Edgewise Therapeutics’s price movement after its last earnings report?
Edgewise Therapeutics reported an EPS of -$0.33 in its last earnings report, beating expectations of -$0.391. Following the earnings report the stock price went down -4.26%.
Which hedge fund is a major shareholder of Edgewise Therapeutics?
Among the largest hedge funds holding Edgewise Therapeutics’s share is RA Capital Management. It holds Edgewise Therapeutics’s shares valued at 163M.
---
Edgewise Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$34.60 (61.01% Upside)
$34.60 (61.01% Upside)
Blogger Sentiment
Bullish
EWTX Sentiment 75%
Sector Average 72%
Sector Average 72%
Hedge Fund Trend
Increased
By 10.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 9.1%
Last 30 Days ▲ 59.4%
Last 30 Days ▲ 59.4%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
207.47%
12-Months-Change
Fundamentals
Return on Equity
-24.51%
Trailing 12-Months
Asset Growth
59.87%
Trailing 12-Months
Company Description
Edgewise Therapeutics
Edgewise Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development and commercialization of innovative treatments for severe, rare muscle disorders. It is developing orally bioavailable, small molecule therapies for musculoskeletal diseases.
---
EWTX Stock 12 Month Forecast
Average Price Target
$34.60
▲(61.01% Upside)
Technical Analysis
Best Analysts Covering EWTX
1 Year
1 Year Success Rate
13/19 ratings generated profit
1 Year Average Return
+59.15%
assigned a buy rating 9 days ago
Copying Leonid Timashev's trades and holding each position for 1 Year would result in 68.42% of your transactions generating a profit, with an average return of +59.15% per trade.
---